JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$5.77B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$5.31B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.14B |
| 4 |
Meta Platforms (Facebook)
META
|
+$2.76B |
| 5 |
Apple
AAPL
|
+$2.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.22B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$1.77B |
| 3 |
Nike
NKE
|
+$744M |
| 4 |
Schwab US TIPS ETF
SCHP
|
+$710M |
| 5 |
Truist Financial
TFC
|
+$605M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.48% |
| 2 | Healthcare | 10.48% |
| 3 | Financials | 8.96% |
| 4 | Consumer Discretionary | 8.42% |
| 5 | Industrials | 7.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3201
IDEAYA Biosciences
IDYA
$3.42B
| $2.6M | ﹤0.01% |
110,561
+74,138
| +204% | +$1.52M |
|
3202
IES Holdings
IESC
$14.8B
| $2.59M | ﹤0.01% |
45,616
+38,821
| +571% | +$1.86M |
|
3203
PUT
Stryker
SYK
$125B
| $2.59M | ﹤0.01% |
8,500
-7,300
| -46% | -$2.11M |
|
3204
Schwab US Aggregate Bond ETF
SCHZ
$10.5B
| $2.59M | ﹤0.01% |
112,062
+6,746
| +6% | +$157K |
|
3205
Green Dot
GDOT
$743M
| $2.58M | ﹤0.01% |
137,820
-39,955
| -22% | -$708K |
|
3206
Ligand Pharmaceuticals
LGND
$5.76B
| $2.58M | ﹤0.01% |
35,734
-12,355
| -26% | -$927K |
|
3207
CALL
Hecla Mining
HL
$9.47B
| $2.58M | ﹤0.01% |
500,000
| – | – |
|
3208
Lucid Motors
LCID
$2.88B
| $2.57M | ﹤0.01% |
37,333
-383
| -1% | -$27.3K |
|
3209
FT Vest US Equity Buffer ETF May
FMAY
$1.41B
| $2.56M | ﹤0.01% |
+65,772
| New | +$2.46M |
|
3210
CALL
Thermo Fisher Scientific
TMO
$213B
| $2.56M | ﹤0.01% |
4,900
+900
| +23% | +$486K |
|
3211
PUT
STMicroelectronics
STM
$46.7B
| $2.55M | ﹤0.01% |
51,000
| – | – |
|
3212
Immatics
IMTX
$1.18B
| $2.55M | ﹤0.01% |
220,879
-4,752
| -2% | -$44.4K |
|
3213
Under Armour
UAA
$2.84B
| $2.54M | ﹤0.01% |
351,999
-40,505
| -10% | -$326K |
|
|
LGF.B
3214
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
| $2.54M | ﹤0.01% |
303,863
+137,175
| +82% | +$1.35M |
|
3215
VanEck Agribusiness ETF
MOO
$972M
| $2.53M | ﹤0.01% |
30,980
+21,372
| +222% | +$1.77M |
|
3216
Dillards
DDS
$9.19B
| $2.53M | ﹤0.01% |
7,743
-27,032
| -78% | -$8.27M |
|
3217
Bausch + Lomb
BLCO
$6.04B
| $2.53M | ﹤0.01% |
125,876
-2,228
| -2% | -$40.4K |
|
|
IBDQ
3218
DELISTED
iShares iBonds Dec 2025 Term Corporate ETF
IBDQ
| $2.53M | ﹤0.01% |
103,619
-300
| -0.3% | -$7.34K |
|
3219
Goldman Sachs MarketBeta International Equity ETF
GSID
$1.09B
| $2.52M | ﹤0.01% |
48,840
-23,259
| -32% | -$1.2M |
|
3220
Caribou Biosciences
CRBU
$145M
| $2.52M | ﹤0.01% |
592,182
-10,796
| -2% | -$48.5K |
|
3221
Scholastic
SCHL
$767M
| $2.52M | ﹤0.01% |
64,715
+2,697
| +4% | +$105K |
|
3222
Park National Corp
PRK
$3.76B
| $2.52M | ﹤0.01% |
24,587
-4,655
| -16% | -$494K |
|
3223
Invesco Leisure and Entertainment ETF
PEJ
$259M
| $2.51M | ﹤0.01% |
60,130
+130
| +0.2% | +$5.3K |
|
3224
Westamerica Bancorp
WABC
$1.38B
| $2.51M | ﹤0.01% |
65,547
-14,575
| -18% | -$583K |
|
3225
OrthoPediatrics
KIDS
$519M
| $2.51M | ﹤0.01% |
57,228
+10,375
| +22% | +$478K |
|
Similar funds
JP Morgan Chase's Q2 2023 Portfolio in Review
As of Q2 2023, JP Morgan Chase held 7,602 positions worth $920B, up 12% from $821B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
JP Morgan Chase deployed $40.5B of net new capital in Q2 2023, opening 674 new positions and adding to 3,069 existing holdings. Its largest new stake was JPMorgan BetaBuilders Emerging Markets Equity ETF: 10,009,525 shares worth $488M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was iShares 0-1 Year Treasury Bond ETF, an estimated $3.22B trimmed.
- JP Morgan Chase's largest Q2 2023 buy was JPMorgan BetaBuilders Emerging Markets Equity ETF: 10,009,525 shares worth $488M.
- JP Morgan Chase added most to Microsoft in Q2 2023, an estimated $5.77B increase.
- JP Morgan Chase's biggest Q2 2023 reduction was iShares 0-1 Year Treasury Bond ETF, cutting an estimated $3.22B.
- JP Morgan Chase fully exited DCP Midstream, LP in Q2 2023, selling an estimated $328M.
- JP Morgan Chase's ten largest holdings make up 20% of its $920B portfolio in Q2 2023.
- JP Morgan Chase opened 674 new positions and closed 737 in Q2 2023.
- JP Morgan Chase's portfolio value rose 12% quarter-over-quarter to $920B.
Based on JP Morgan Chase's 13F filing for Q2 2023, filed 11 Aug 2023.